1W. Zhang,Terumasa Tsuchiya,Y. Yasukochi. Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia[J] 1999,Journal of Human Genetics(5):293～299
5LUO B, ABRAMS GA, FALLON MB. Endothelin- 1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction [ J ]. J Hepatology, 1998, 29:571-578.
6FISHER JW. Erythropoietin: physiology and pharmacology update [J]. Exp Biol Med (Maywood), 2003, 228(1): 1 - 14.
7TACKE F, SCHOFFSKI P, LUEDDE T. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease [J ]. Scand J Gastroenterol,2004, 39 (3) : 259 - 266.
8GASTRO A, JIMENEZ W, CLARIA J, et al. Impaired responsiveness to angiotensin Ⅱ in experimental cirrhosis:role of nitric oxide [J]. Hepatology, 1993, 18 (2):367 - 372.
9KOUREMBABAS S, MEQUILLAN LP, LEUNG GK, et al. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia [J]. J Clin Invest, 1993, 92:99-104.
10CHEN YX, WAN SC, ZHAO GN, et al. Plasma endothelin levels in cirrhotic patients anti their correlation with atrial natriure peptide [J]. Chin Med J (Engl), 1993,106 (9): 643-646.
